The Billion Dollar Blindspot
The Billion Dollar Blindspot is an independent publication examining women’s health, Healthcare AI and the capital shaping the future of healthcare.
It brings an institutional investment lens to a field too often discussed solely as a healthcare problem or social cause. The objective is to understand where investment opportunities are emerging, how markets are developing and what family offices and institutional investors need to know before allocating capital.
What you will receive
The Daily Capital Briefing
A concise briefing on the developments shaping healthcare investment, including women’s-health innovation, Healthcare AI, venture capital, public markets, funding, transactions and relevant scientific developments.
Each edition explains not only what happened, but why it matters and what the investment implications may be.
Investment analysis
Longer-form analysis examining capital formation, market development, investment judgement and the structural forces influencing where capital flows and where it hesitates.
Research and frameworks
Original research, investment frameworks and practical guides designed to help investors understand and evaluate opportunities across women’s health and healthcare innovation. The definitive versions of major reports and research are published at billiondollarblindspot.com.
Who this publication is for
The Billion Dollar Blindspot is written for:
Family offices and private investors
Institutional allocators and investment professionals
Fund managers and healthcare investors
Founders and healthcare innovators
Policymakers and ecosystem leaders
Anyone seeking a more rigorous understanding of women’s-health investment
About Maryann Selfe
I’m Maryann Selfe, an institutional investor and the Founder and Chief Investment Officer of Calabar Capital.
After more than two decades working across private banking, portfolio construction, investment risk and capital allocation, I now focus on the investment infrastructure needed to connect long-term capital with opportunities in women’s health.
I am the author of The Billion Dollar Blindspot: Why Women’s Health Is the Investment Opportunity of Our Time and the Founder and President of FemmeHealth Alliance, an independent Swiss non-profit ecosystem and convening platform.
My work is grounded in a simple conviction: compelling healthcare needs do not automatically become investable opportunities. Markets develop when scientific evidence, specialist expertise, commercial models and appropriate capital come together.
How the work fits together
The Billion Dollar Blindspot is my independent publishing and intellectual platform.
Calabar Capital is the institutional investment platform I am building around Women’s Health and Healthcare AI.
FemmeHealth Alliance is an independent non-profit ecosystem and convening platform. It has no commercial investment mandate.
Each has a distinct role in improving how women’s-health innovation is understood, connected and financed.
Subscribe
Subscribe to receive The Daily Capital Briefing and further analysis on women’s health, Healthcare AI and healthcare investment.
All content is provided for informational and educational purposes only. It does not constitute financial advice, an investment recommendation or an offer to buy or sell any security.
